The following is a summary of “Optimal PSA density threshold for prostate biopsy in benign prostatic obstruction patients ...

A new study published in the journal of Research and Reports in Urology showed that lesion size was a crucial predictor of ...

The global fusion biopsy market, valued at US$0.61 billion in 2023, is forecasted to grow at a robust CAGR of 7.1%, reaching ...

Mark Hinton, CTO at Lucida Medical, said: “Pi is medical device software that is CE-approved for use in clinics. We developed ...

Adenocarcinoma grows in the tissue of the prostate gland, but other types of cancer can also start in the prostate or spread ...

A five-year study on men that had just the cancerous portion of their prostate glands destroyed shows that the procedure averted cancer recurrence in most patients while preserving urinary and sexual ...

Bill Faulkner had long approached prostate cancer testing with skepticism. For almost a decade, the 73-year-old had avoided ...

Investigators assessed whether MRI alone can identify all cases of Gleason grade group 2 or higher disease in patients on prostate cancer active surveillance.

MEN have been warned against relying on at-home prostate tests, as they could give inconsistent or misleading results. The ...

DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc., will ...